Colinz Laboratories Ltd

Colinz Laboratories Ltd

None%
- close price
About

Established in 1986, Colinz Laboratories is Limited is engaged in the manufacturing of Pharmaceutical Formulations like
Allopathic, Ayurvedic and Nutraceuticals in dosage forms of Tablets, Capsules, Ointments, Injectables, Syrups, etc. The company has certain specialized products for Gynecology, cardiology, gastroenterology etc.

Key Points

Product Portfolio:[1]
The company is manufacturing and developing a number of products for various therapeutic segments like:
a) Allopathy:[2]
The company manufactures various Oncology products like Imatinib, Erlotinib, Letrozole, etc. Anti-retroviral like Lopinavir, Indinavir, Ritonavir, etc. and also products belonging to therapeutic segments like Antibiotic; Anti pyretic Anti- Fungal, Anti-malarial, Anti-viral, etc.
b) Ayurvedics:[3]
The company manufactures many Ayurvedic products like Anti-diarrhoeals, Anti-pyretics, Anti-inflammatories, Anti-spasmodics, Cough Syrups, Apetite Stimulating Agents, Memory Boosters, Anti-piles, Antacids, Liver Tonic, etc.
c) Nutraceuticals:[4]
Major products manufactured in the Nutraceutical category are Spirulina Tabs /caps, Spirulina With Vitamins & Minerals, Omega 3 Fatty Acids Caps in Soft gel, Cod-liver Oil With Vitamin Caps in Soft Gel, Collagen, Glucosamine & Chondroitin Tabs, Amino acids tabs/caps, etc.

  • Market Cap Cr.
  • Current Price
  • High / Low /
  • Stock P/E
  • Book Value
  • Dividend Yield %
  • ROCE %
  • ROE %
  • Face Value

Pros

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Industry:

Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Operating Profit
OPM %
Interest
Depreciation
Profit before tax
Tax %
EPS in Rs
Raw PDF
Upcoming result date: 31 July 2024

Profit & Loss

Figures in Rs. Crores

Operating Profit
OPM %
Interest
Depreciation
Profit before tax
Tax %
EPS in Rs
Dividend Payout %
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Figures in Rs. Crores

Equity Capital
Reserves
Total Liabilities
CWIP
Investments
Total Assets

Cash Flows

Figures in Rs. Crores

Net Cash Flow

Ratios

Figures in Rs. Crores

Debtor Days
Inventory Days
Days Payable
Cash Conversion Cycle
Working Capital Days
ROCE %

Shareholding Pattern

Numbers in percentages

1 Recently
Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
36.41% 36.41% 36.38% 66.01% 65.93% 66.00% 66.00% 66.00% 66.00% 66.00% 66.00% 66.00%
0.07% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
0.00% 0.07% 0.07% 0.12% 0.12% 0.12% 0.12% 0.00% 0.00% 0.00% 0.00% 0.00%
63.52% 63.52% 63.56% 33.88% 33.95% 33.89% 33.88% 34.00% 34.00% 34.00% 34.00% 34.00%
No. of Shareholders 2,4212,6072,8212,6462,7942,8632,8112,8252,8732,9152,9292,980

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents